This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cornell, S. Articles by Briggs, A. Search for Related Content Social Bookmarking                   What's this?

Newer Treatment Strategies for the Management of Type 2 Diabetes Mellitus

15124 Ginger Creek Lane, Orland Park, IL 60467sacornell{at}aol.com(home);scorne@midwestern.edu(work)

Amber Briggs, PharmD

Community Pharmacy Practice Residency, Dominicks Pharmacy, Calumet City, IL; Midwestern University Chicago College of Pharmacy.

Type 2 diabetes mellitus is a multiorgan, metabolic disease associated with multiple microvascular and macrovascular complications. The incidence of type 2 diabetes is growing at an alarming rate. Achieving and maintaining near-normal blood glucose and glycosylated hemoglobin levels (A1C) are of the utmost importance. Existing treatment options for managing type 2 diabetes, which have primarily included sulfonylureas and biguanides, are insufficient at achieving these treatment goals alone, particularly if used long term. The need to explore newer and better treatment options that provide longer lasting glucose control and at the same time focus on targeting cardiovascular risk factors to minimize and prevent the serious complications associated with this multifaceted disease becomes quite obvious.

Key Words: Type 2 diabetes • A1C • nonpharmacological • pharmacological • algorithm.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?